Loading...
Although mortality risk is high shortly after ST-segment elevation myocardial infarction (STEMI), long-term mortality risk in a population treated with contemporary invasive and medical management is not well described.
Using a population-based registry, researchers identified nearly 19,000 patients with first-time STEMI undergoing primary percutaneous coronary intervention (PCI) in Western Denmark between 2003 and 2018. They matched each patient by age and sex to five individuals from the general population without known coronary artery disease. The median age was 64 years, and 26% were women.
Baseline comorbidities were similar between groups. Compared with controls, mortality was significantly increased in the STEMI cohort from 0 to 90 day…